Digital Health – What are the real-world opportunities and potential barriers to adoption?

SMi Reports: Renowned industry expert PharMechceutics Ltd to present on the Pre-Filled Syringes and Injectable Drug Devices pre-conference workshop taking place 12th January 2021.
By: SMi Group
 
 
1200 X 627
1200 X 627
 
Spread the Word
Listed Under

Tag:
* PFSSMi

Industry:
* Health

Location:
* Kensington - London, Greater - England

Subject:
* Features

KENSINGTON, U.K. - Sept. 14, 2020 - PRLog -- Digital Health continues to create significant excitement in the scientific press but to date its adoption has not reflected that level of interest. This workshop explores:
• What is digital health?
• What are the potential opportunities for digital health?
• What have been the barriers to adoption?
• How might these barriers be mitigated?

The workshop will take the participants through a structured process to challenge them how to create a potential value proposition for the use of digital health in clinical development, to consider how they might validate that value proposition and develop a simulation model to demonstrate that value proposition.
View the full agenda and speaker line-up online: www.pre-filled-syringes.com/prlog2

Benefits of attending:

This workshop is targeted at individuals from all disciplines in the pharmaceutical product development space who have been intrigued or frustrated by the potential for digital health not having being more universally adopted.

The Workshop takes a structured design approach, which has broader applicability, to developing a compelling opportunity for digital health.

Workshop Leader: Andrew Dundon, Founder, PharMechceutics Ltd
Andrew is founder of PharMechceutics Ltd. an independent consultancy specialising in supporting clients to design, develop and industrialise robust, differentiated patient centric drug delivery systems. Andrew was formerly Head of Device Engineering at GSK R&D.

At GSK, Andrew led or assumed accountability for key deliverables in the development and market authorisation of the pMDI counter, Veramyst/Mistrpo™, Ellipta™ inhaler, a platform autoinjector and a number of novel drug delivery devices.

Andrew has a passion for influencing how drug delivery systems should be most effectively developed using a risk-based approach informed by the regulatory framework within which companies are required to operate.

Register online: www.pre-filled-syringes.com/prlog2

Who should attend:
• Drug-delivery developers
• Medical Device Engineers
• Primary Packaging material designers
• Secondary packagers
• Smart device developers
• Training device developers
• Device-safety solution providers
• Drug developers

Sponsored by BD Medical| Harro Hoefliger | Nemera | Owen Mumford | Zeon |

--- ENDS --

Contact Information:

For media enquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email:  hsidhu@smi-online.co.uk

Contact
Jinna Sidhu
***@smi-online.co.uk
End
Email:***@smi-online.co.uk
Posted By:***@smi-online.co.uk Email Verified
Tags:PFSSMi
Industry:Health
Location:Kensington - London, Greater - England
Subject:Features
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share